Jump directly to content

Matchmaking & Expertise Session: New Antimicrobial Drugs and Vaccines

HERMES: Horizon Europe Matchmaking and Expertise Session

Looking for the right expertise and partners for upcoming Horizon Europe calls? Horizon Europe Matchmaking and Expertise Session (HERMES) is a virtual matchmaking event bringing organisations together to build strong consortia and develop new project collaborations.

The first HERMES session focuses on the development of new antimicrobial drugs and vaccines. 

During the session, 11 organisations from across Europe will present their expertise, technologies and capabilities, and what they can contribute to future European consortia. As a participant, you will have the opportunity to identify complementary expertise, find potential consortium partners and make new connections for future project proposals. 

Who should attend? 

The session is aimed at companies and organisations planning to participate in upcoming Horizon Europe calls and other European research and innovation programmes, whether you are looking to build a consortium, join one or find specific expertise to strengthen a project idea. 

Join to: 

  • Discover expertise and capabilities relevant to upcoming calls  

  • Identify potential partners for your consortium  

  • Explore how different organisations could contribute to future projects  

  • Connect with companies, research organisations and innovation actors across Europe  

  • Start conversations that could develop into future Horizon Europe proposals  

Calls in focus 

This HERMES session is particularly relevant for organisations interested in forming consortia and preparing proposals for: 

Meet potential partners and complementary expertise 

The first HERMES session brings together 11 organisations from across Europe with expertise relevant to the development of antimicrobial drugs and vaccines: 

  • From surface shaving of intact pathogens to epitope-guided vaccine antigen candidates
    Roger Karlsson, Sahlgrenska University Hospital
  • First-in class virulence factor inhibition
    Rory Triniman, Veirulence Ltd
  • Effective next-generation antibacterials for all
    Alan Hennessy, GARPD 
  • One Health epidemiology for reducing antimicrobial use and resistance in aquaculture
    Fernando Mardones, University of Edinburgh
  • Avenues for AMR research and clinical trials
    Jesse J. Waggoner, IRCCS-Negrar 
  • Cutting-Edge Therapies to Combat Emerging Bacterial Pathogens
    Concepción González-Bello ,CiQUS
  • Dynamic Antimicrobial Nanonmaterials
    Ignacio Insua, CiQUS
  • The broader health, economic and societal impact of investments in infectious disease prevention, diagnostics and treatment
    Cornelis Boersma, Health-Ecore
  • siRNA therapeutics – from bench to bedside
    Julia Grönros, Ribocure 
  • Advancing Anti-Infective Research: Integrating Infection Biology, Antimicrobials and Vaccines
    Nadine Kraupner, RISE
  • Environmental dimensions of AMR and One health: understanding evolution, emergence and dissemination of AMR
    Nachiket P. Marathe, Institute of Marine Research
  • AMR Project Portfolio of the European Vaccine Initiative
    Irina Meln, European Vaccine Initiative (EVI) 

Meet the experts

Each organisation will give a short expert presentation focusing on its core expertise, technologies and capabilities, potential contributions to future European consortia, and the types of partnerships and roles it is seeking. 

About HERMES 

HERMES – Horizon Europe Matchmaking and Expertise Session is a meeting series organised by RISE to strengthen European collaboration and facilitate early consortium building for upcoming Horizon Europe calls and other European research and innovation programmes. 

By making relevant expertise and capabilities visible at an early stage, HERMES aims to help organisations find complementary partners and create new opportunities for collaborative project development.

Session 1: Development of new antimicrobial medicines and vaccines
11 Nov 2026
14:00-16:30
Digital, via Teams
10 November 2026

Free of charge.

Unlimited
Digital,

Dirk Weigelt

Innovations- och processledare
+46 10 516 67 64 Read more about Dirk
Profile image

Contact Dirk

CAPTCHA

* Mandatory 

By submitting the form, RISE will process your personal data.

14:00–14:10 Welcome and introduction 
Introduction to HERMES and the funding opportunities in focus. 

14:10–15:10 Presentation block 1 
Short presentations from the participating organisations focusing on expertise, capabilities and potential contributions to future consortia. 

15:10–15:20 Short break 

15:20–16:20 Presentation block 2 
Short presentations from the participating organisations focusing on expertise, capabilities and potential contributions to future consortia. 

Division: Division Life Science Drug development

Dissolution and release from tablets and capsules with dissolution instrument. Analyses according to GMP or exploratory.

Name of service (page headline, shown in promos – maximum of 70 characters incl. spaces): Dissolution testing of tablets and capsules Lead (include SEO-words and the main benefits for your target groups. Stick to one paragraph, maximum 2-3 sentences):

RISE offers dissolution analyses for formulations such as tablets and capsules under development or for GMP quality control of finished product. We perform method development, method validation and tech transfer of existing methods, we focus on robust arrangements adapted to the product, the dosage form and regulatory requirements.

Purpose/Benefit:

Dissolution analysis is used to show how quickly and to what extent a substance is released from, for example, a tablet under defined conditions.  

The testing is used in formulation development as well as process development, and as part of quality control for the finished product. 

Dissolution analyses are performed on both immediate release dosage forms and extended and delayed release dosage forms.

RISE can perform: 

  • dissolution testing for tablets and capsules, as well as other formulations on request
  • method development and optimisation adapted to product and area of use 
  • method validation and tech transfer of existing methods
  • support in formulation and process development
  • routine analyses according to GMP   
Method (what/which methods are used to perform the service):

Dissolution testing is performed primarily according to the pharmacopoeial method Ph. Eur. 2.9.3 and USP <711>. These are harmonised for dissolution testing of oral solid formulations.                         We perform analyses mainly on tablets and capsules, but other formulations are also possible.             

Instrument

Our automated dissolution instrument is qualified for GMP analysis and equipped with extraction probes, temperature monitoring in all vessels and the possibility of automated filtration of release samples. The automation contributes to high reproducibility and efficient sample handling.  

The analysis is done either with rotating paddles or baskets, which is most common for tablets and capsules. Samples are withdrawn at defined times. Quantification of released substance is mainly done with LC UV or LC CAD, depending on the product's properties.

Delivery (what does the client get after performed service – e.g. a report, certificate etc.):

Reporting is done by agreement and can include anything from a simple performance report to a full analytical method validation report or tech transfer report. We adapt the structure and documentation to the phase of the project, the customer's needs and applicable regulatory requirements.

Area: Pharmaceuticals Contact person (Enter one name per field. Activated personal contact pages will appear automatically):
Mattias P Persson, Forskare
Anna Stenemyr
Dissolution instrument at RISE Sweden
Field measurements: No Price type: 1 Division: Division Life Science Preparation: No preparation required Certification and marking: Not applicable Type of service: Not applicable Instrument: Not applicable General area: Not applicable Delivery level: Not applicable
mattias.p.persson@ri.se,anna.stenemyr@ri.se
/en/personal-data-processing/candidate-database
3. Good health and well-being
Purpose - Header: Purpose Metod - Header: Method Delivery - Header: Delivery More information - Header: Mer information
form
Bildtext: Dissolution instrument at RISE Södertälje Sweden Drug development Tjänstetyp tagg: Provning

ReSCALE – Reasoning Agents for Sustainable Chemical Assessment

ReScale
Reasoning agent structured workflow

ReSCALE develops AI-based reasoning agents to support chemical safety, life-cycle assessment, and sustainable substitution in line with Safe and Sustainable by Design (SSbD). By integrating data, predictive models, and scientific knowledge, the project enables experts to make faster, more transparent decisions.

Deltagare
Active
Artificial intelligence Formulated products Risk and safety
Region Stockholm
1,5 år
3 120 500 kr
Division: Division Life Science

Challenge: complex decisions for chemical safety and sustainability

The development and use of chemicals place increasing demands on minimizing risks to human health and the environment. At the same time, current decision-making processes are often fragmented, where data from chemical databases, predictive models, and life cycle assessment (LCA) must be analyzed manually and separately. This makes it difficult for companies and authorities to quickly identify safer and more sustainable alternatives, especially in the context of substitution and the implementation of Safe and Sustainable by Design (SSbD).

Solution: AI-based reasoning agents for chemical assessment

Within ReSCALE, a new type of digital decision support is developed based on AI and so-called reasoning agents. These act as an “AI co-scientist” that can plan analyses, retrieve and integrate data from multiple sources, and synthesize and interpret results. By combining chemical databases, predictive models such as QSAR and toxicity models, scientific literature, and sustainability data, a more holistic and efficient chemical assessment becomes possible.

Customer value: better and faster decision-making

For industry and other stakeholders, this means that complex assessments can be performed faster, more systematically, and with greater transparency. The system supports the identification of safer and more sustainable alternatives, for example in solvent substitution, and enables trade-offs between functionality, safety, and environmental impact. This contributes to reduced risks, shorter development times, and stronger support for innovation and regulatory decision-making.

Pilot and application: focus on solvent substitution

The project includes a concrete pilot case where the technology is applied to solvent substitution – a priority area in industry. Existing tools and databases are integrated to demonstrate how AI-based reasoning agents can support experts in identifying and evaluating alternative chemicals that meet both performance and sustainability requirements.

Contribution to sustainable development and SSbD

ReSCALE contributes to the transition towards more sustainable and circular use of chemicals by operationalizing the principles of Safe and Sustainable by Design. By integrating safety, functionality, and life-cycle perspectives early in the development process, the project supports the creation of next-generation chemicals, materials, and processes that are safer for both people and the environment.

Profile image

Contact Petru

CAPTCHA

* Mandatory 

By submitting the form, RISE will process your personal data.
Project end date: Bildtext: Reasoning agent structured workflow Drug development Sekundär områdes navigation: Health and life science

Determination of organic solvent residue with Headspace GC in solid or liquid samples. Quality level GMP or exploratory.

Name of service (page headline, shown in promos – maximum of 70 characters incl. spaces): Determination of residual solvents Lead (include SEO-words and the main benefits for your target groups. Stick to one paragraph, maximum 2-3 sentences):

RISE offers determination of organic solvent residues with Headspace GC in solid and liquid samples. The analysis can be performed to GMP quality level according to ICH Guidelines for drug substance and drug product, according to Ph Eur 2.4.24, or exploratory.

Purpose/Benefit:

Residual solvent analysis aims to ensure the safety, quality and regulatory compliance of products and processes where organic solvents are used.  

The analysis is a tool in, for example, work to protect health and the environment, to maintain high product quality and to comply with laws and standards, especially in the areas of pharmaceuticals, food, chemistry and the environment.  

Areas of application 

  • Safety. Organic solvents can cause negative effects on health and the environment. The analysis ensures that the levels are below permitted limits.
    • Monitoring: Analysis of solvent residues as part of the monitoring of solvent emissions and exposures to protect the environment and personnel                                                                                       
  • Quality control. Residues of solvents in a product can affect the stability, taste, smell or function of the product. Analysis verifies that manufacturing produces a clean and consistent product.
    • Pharmaceuticals: Ensuring that the active substance and finished product do not contain harmful levels of residual solvents from the manufacturing process
    • Food and packaging: Control of solvents from printing inks and adhesives in the packaging that can migrate to the food                                                                                                              
  • Regulatory compliance. Legislation and guidelines, such as ICH Q3C for pharmaceuticals or food law within EU, set maximum limits for residual solvents. Analysis is required to demonstrate compliance.                    
  • Process optimisation. The analysis results can be used to improve process steps such as drying or purification in a manufacturing process, to reduce solvent residues and make the process more efficient.
Method (what/which methods are used to perform the service):

Gas chromatography (GC) is the standard method for the analysis of solvent residues. The most widely used technique is Headspace GC (HS GC), where a dissolved sample is heated and volatile organic solvents are analyzed in the gas phase. The most common detection technique is Flame Ionisation Detection (FID).   

The method is quantitative, robust, highly reproducible and standard in quality control QC. Furthermore, the method is very sensitive, solvent concentrations at ppm and down to ppb levels can be analysed, and it is suitable for volatile and semi volatile organic solvents.  

RISE performs both GMP analyses according to ICH Guidelines (ICH Q3C), analyses according to Ph Eur 2.4.24 and exploratory analyses for research and development purposes.  

Delivery (what does the client get after performed service – e.g. a report, certificate etc.):

Results are reported in agreement with the customer, for example in the form of a written report, or a Certificate of Analysis CoA, or as a table with raw data.

Area: Pharmaceuticals Contact person (Enter one name per field. Activated personal contact pages will appear automatically):
Krzysztof Laniewski, Projektkoordinator
Anna Stenemyr
Headspace GC, RISE Södertälje Sweden
Field measurements: No Price type: 1 Division: Division Life Science Preparation: No preparation required Certification and marking: Not applicable Type of service: Testing / Analysis / Evaluation Instrument: Not applicable General area: Not applicable Delivery level: Not applicable
krzysztof.laniewski@ri.se,anna.stenemyr@ri.se
/en/personal-data-processing/candidate-database
3. Good health and well-being
Purpose - Header: Purpose Metod - Header: Method Delivery - Header: Delivery More information - Header: Mer information
form
Bildtext: Headspace GC instrument at RISE Södertälje Sweden Drug development Tjänstetyp tagg: Provning

Determination of water content by Karl Fischer (KF) titration according to GMP or exploratory

Name of service (page headline, shown in promos – maximum of 70 characters incl. spaces): Water content by Karl Fisher KF Lead (include SEO-words and the main benefits for your target groups. Stick to one paragraph, maximum 2-3 sentences):

RISE offers determination of water content by Karl Fischer titration (KF) in solids and liquids.
Analyses can be performed to GMP quality level according to Ph Eur for drug substance and drug product, or exploratory.

Purpose/Benefit:

The presence of water in a product can, for example, affect the quality and shelf life of pharmaceuticals and food, the course of reactions in chemical processes, and the safety and function of oils, fuels and solvents.  

With Karl Fischer titration, the water content (moisture content) of solids or liquids is determined both qualitatively and quantitatively with very high accuracy. Content levels from trace amounts up to percentages of a water can be analyzed. 

RISE performs both GMP analyses according to the European Pharmacopoeia Ph Eur and exploratory studies for research and development purposes.   

Method (what/which methods are used to perform the service):

Karl Fischer titration is a fast, selective, and precise method for water content determination. It is a standard method in the pharmaceutical industry, chemical industry, food analysis, petrochemistry and quality control laboratories. 

Two method variants can be performed:  

  • Volumetric Karl Fischer titration (GMP according to Ph Eur 2.5.12), for samples containing water at 0.1 – 100%
  • Coulometric Karl Fischer titration (GMP according to Ph Eur 2.5.32), for samples with very low water contents, down to ppm levels
Delivery (what does the client get after performed service – e.g. a report, certificate etc.):

Results are reported in agreement with the customer, for example in the form of a written report, as a Certificate of Analysis CoA, or as a table with raw data.

 

Area: Pharmaceuticals Contact person (Enter one name per field. Activated personal contact pages will appear automatically):
Krzysztof Laniewski, Projektkoordinator
Anna Stenemyr
Karl Fischer titrator at RISE Södertälje Sweden
Field measurements: No Price type: 1 Division: Division Life Science Preparation: No preparation required Certification and marking: Not applicable Type of service: Testing / Analysis / Evaluation Instrument: Not applicable General area: Not applicable Delivery level: Not applicable
krzysztof.laniewski@ri.se,anna.stenemyr@ri.se
/en/personal-data-processing/candidate-database
Purpose - Header: Purpose Metod - Header: Method Delivery - Header: Delivery More information - Header: Mer information
Request for quote
form
Bildtext: Karl Fischer titrator for determination of water content, RISE Södertälje Drug development Tjänstetyp tagg: Provning

Analysis of Specific surface area, Pore size and Pore size distribution by BET. Quality level GMP or exploratory.

Name of service (page headline, shown in promos – maximum of 70 characters incl. spaces): Specific surface by BET Lead (include SEO-words and the main benefits for your target groups. Stick to one paragraph, maximum 2-3 sentences):

RISE offers analyses according to GMP or exploratory of Specific surface area using the Brunauer-Emmett-Teller (BET) method to gain information about a material's reactivity. Also measurements of Pore size and Pore size distribution. Analysis on solid samples such as powders, tablets, porous materials and catalysts.

Purpose/Benefit:

The specific surface area of a solid provides information about the reactive properties of the material. The dissolution rate of a drug is often correlated to the specific surface area, and the same applies to performance of, for example, batteries and catalysts.                                                   By measuring Specific surface area, information is obtained regarding the quality and functionality of the material.  

Method (what/which methods are used to perform the service):

The sample is prepared for analysis by degassing under vacuum at an elevated temperature or in a stream of inert gas, such as nitrogen.   

 During the analysis, inert gas molecules with a known area, such as nitrogen, are introduced to the sample. This is done in several rounds in a certain amount and to a certain pressure. The surface area of the sample is then determined by measuring exactly how many gas molecules are needed to adsorb directly onto the surface of the sample and first covering it in a so-called monolayer, and then in multilayers.  

The specific surface area is then calculated based on the mass of the sample.   

Using BET, RISE can analyse: 

  • Specific surface, Pore size and Pore size distribution
  • according to GMP quality level or exploratory
  • on solids such as powders, tablets, porous materials, catalysts                                                                                                                                                                                                                                   
Delivery (what does the client get after performed service – e.g. a report, certificate etc.):

Results in report format as agreed with client.

Area: Pharmaceuticals Contact person (Enter one name per field. Activated personal contact pages will appear automatically):
Hanna Nylén
Anna Stenemyr
BET at RISE KPL Södertälje Sweden
Field measurements: No Price type: 1 Division: Division Life Science Preparation: No preparation required Certification and marking: Not applicable Type of service: Testing / Analysis / Evaluation Instrument: Not applicable General area: Not applicable Delivery level: Not applicable
hanna.nylen@ri.se,anna.stenemyr@ri.se
/en/node/18517
Purpose - Header: Purpose Metod - Header: Method Delivery - Header: Delivery More information - Header: Mer information
Request for quote
form
Bildtext: BET instrument at RISE Södertälje Drug development Tjänstetyp tagg: Provning

Stability studies of product or substance performed according to GMP or exploratory

Name of service (page headline, shown in promos – maximum of 70 characters incl. spaces): Stability studies Lead (include SEO-words and the main benefits for your target groups. Stick to one paragraph, maximum 2-3 sentences):

RISE offers stability studies for quality evaluation of a product or substance during storage.
Samples are held at 25°C/60%RH, 40°C/75%RH, 5°C or -18°C in validated climate cabinets/fridge-freezers with continuous monitoring, temperature and humidity log.
Studies performed GMP according to ICH Guidelines on drug substance/product, or exploratory.

Purpose/Benefit:

Stability studies are performed on chemical substances and on products such as pharmaceuticals, food, beverages and cosmetics to map the quality of the material over time. Factors that may affect quality include temperature, humidity and light. The result of the studies can be used to determine shelf-life, re-test date or recommended storage conditions.

Method (what/which methods are used to perform the service):

Representative samples of the material, with a specified quality by reference to parameters such as appearance, content, chemical purity, pH, are placed in specific environments over a selected period of time. The quality of the material is monitored during the period by sampling at certain times, the samples are analysed according to the specified quality parameters and results are compared with the original values.

RISE conducts both regulatory GMP studies according to ICH guidelines (ICH Q1A), or exploratory studies for research and development purposes.   Both short-term studies (weeks) and long-term studies (several years) are possible.

RISE can offer the following environments for stability studies: 

  • 25°C±2°C / 60%±5% RH, standard
  • 40°C±2°C / 75%±5% RH, accelerated
  • 5°C±3°C, fridge
  • -20°C±5°C, freezer

Climate cabinets have controlled temperature and humidity, fridge/freezers controlled temperature. They are qualified according to GMP requirements and placed in a room only accessible to authorized personnel. Humidity and temperature are electronically logged and stored in cloud storage in a web-based system. In the event of temperature or humidity outside specified interval, the system alerts responsible personnel via e-mail or text message around the clock.

 

RISE can also perform several types of analyses according to GMP on sampled material, e.g. assay and purity (LC, GC, NMR), appearance, water content (KF), pH. Samples can also be sent to external laboratories.                                                                                                                                                                

We can also develop and validate stability-indicating analysis methods, including forced degradation where the substance/product is exposed to heat, light, acid, base and oxidizing agent to induce formation of eventual degradation products.

Delivery (what does the client get after performed service – e.g. a report, certificate etc.):

A study plan is agreed upon with the customer before the start of the study. Interim reports can be issued during the course of the study and a summary stability report after study completion.                                                                                                                                      

 

Area: Pharmaceuticals Contact person (Enter one name per field. Activated personal contact pages will appear automatically):
Hanna Nylén
Anna Stenemyr
Stability chambers RISE
Field measurements: No Price type: 1 Division: Division Life Science Preparation: No preparation required Certification and marking: Not applicable Type of service: Testing / Analysis / Evaluation Instrument: Not applicable General area: Not applicable Delivery level: Not applicable
hanna.nylen@ri.se,anna.stenemyr@ri.se
/en/about-rise/operations/mission-governance/policy-documents/privacy-policy
Purpose - Header: Purpose Metod - Header: Method Delivery - Header: Delivery More information - Header: Mer information
form
Bildtext: Climat chambers at RISE Drug development Tjänstetyp tagg: Provning

End-to-end CDMO services for biologics

Biological substances

Developing biological drugs – from oligonucleotides, peptides, PROTACs, and conjugates to antibodies and mRNA – places high demands on both substance and product levels. Stability, reproducibility, maintained biological activity, and controlled delivery are critical factors. Advanced formulations, including nanoformulations, require deep expertise in particle characterization, functional analyses, and in vivo behavior.

RISE supports the development of biological drugs through detailed characterization, functional assessment, nanoformulation, and analytical strategies. Our expertise ensures quality, reproducibility, and biological performance across the entire development chain, from early discovery to clinical material.

How we can support you

 

Characterization of API

+

Functional assessment

+

Formulation expertise, including nanoformulation

+

Toxicity and immunogenicity risk assessment

+

Analytical methods and laboratory support

+

 

Tailored strategies

Each biological substance and product requires a customized strategy to ensure that all regulatory and biological parameters are addressed. We provide guidance and support in:

  • Substance characterization and functional analysis
  • Formulation selection and stability
  • Toxicity, immunogenicity, and risk mitigation
  • Strategic planning and regulatory documentation

Why RISE?

With decades of experience, our multidisciplinary teams combine analytical expertise, biological insight, and formulation knowledge. We deliver solutions and guidance that enable the development of complex biological drugs and nanoformulated products with high reproducibility and regulatory feasibility.

Collaboration in biological drug development

RISE can support projects at all stages of development, from early substance discovery to clinical material, with flexible, science-based solutions. Collaboration may include:

We provide expert-level support in the characterization and analytical evaluation of oligonucleotides, peptides, conjugates, PROTACs, and antibodies, as well as assessment of biological function, formulation, and nanoformulation. Our laboratories also develop and deliver analytical methods to support preclinical studies.

For longer-term development partnerships, we offer guidance across multiple stages of substance and product development, integrating strategies for formulation, biological function, and regulatory requirements.

We also engage in joint research projects focused on new biological modalities, advanced delivery systems, and analytical technologies, and we develop and validate innovative methods that support the next generation of biological drugs.

Håkan Hollmark

Försäljning-och Marknadschef
+46 10 516 65 57 Read more about Håkan
Profile image

Contact Håkan

CAPTCHA

* Mandatory 

By submitting the form, RISE will process your personal data.
Hide menu: Off Contact form:
CAPTCHA
By submitting the form, RISE will process your personal data.
Contact form title: Contact us Contact form description:

Ready to develop your next pharmaceutical product with us? Reach out and we’ll get back to you shortly.

Hantering av personuppgifter: /en/about-rise/operations/mission-governance/policy-documents/privacy-policy
bg_8
Division: Division Life Science Drug development

Developing biologics

Developing biologics
Drug development Biologics

The development of biologics demands precision, robustness and a deep understanding of how structure, process and formulation interact. RISE provides integrated support across the entire development chain – from early drug substance characterisation to formulation, analytical method development and preparation for clinical material.

RISE offers end-to-end services for biologics development, where drug substance and product are developed in concert. We combine structural and functional analysis, formulation expertise and regulatory guidance to ensure each biologic is stable, reproducible and ready for clinical trials. Our multidisciplinary teams and laboratories enable a smooth workflow from early discovery to clinical material production, with quality, safety and biological performance at the forefront.

Services and areas of expertise

 

Drug substance characterisation

+

Evaluation of biological function

+

Formulation and analytical method development

+

Stability and reproducibility

+

Vaccine development

+

 

Why choose RISE?

RISE combines advanced analytical capabilities, regulatory insight and hands-on experience with complex biologics. Our teams work cross-functionally and can take responsibility for either specific segments or the full development chain.

As an independent research institute, we offer a neutral, long-term partner focused on quality, reproducibility and sustainable development – not short-term delivery targets.

Flexible collaboration

RISE works with biotech and pharmaceutical companies at all stages of development. We can undertake targeted technical assignments or act as a fully integrated development partner.

Our services include:

  • Characterisation and analysis of oligonucleotides, peptides, conjugates and PROTACs
  • Evaluation of biological function and formulation
  • Production of clinical material
  • Support for regulatory strategy and CMC documentation

Whatever the scale of the assignment, our goal remains the same: to create a predictable, knowledge-driven and quality-assured development process that moves your project confidently towards clinical trials and regulatory review.

Håkan Hollmark

Försäljning-och Marknadschef
+46 10 516 65 57 Read more about Håkan
Profile image

Contact Håkan

CAPTCHA

* Mandatory 

By submitting the form, RISE will process your personal data.
Offer-pages:
End-to-end CDMO services for biologics
End-to-end CDMO services for small molecules
Division: Division Life Science Drug development